Paraskevaidis I, Farmakis D, Papingiotis G, Tsougos E. Inflammation and Heart Failure: Searching for the Enemy-Reaching the Entelechy. J Cardiovasc Dev Dis 2023;10. [PMID: 36661914 DOI: 10.3390/jcdd10010019][Reference Citation Analysis]
2
Treille de Grandsaigne H, Bouisset F, Porterie J, Biendel C, Marcheix B, Lairez O, Labaste F, Elbaz M, Galinier M, Delmas C. Incidence, management, and prognosis of post-ischaemic ventricular septal defect: Insights from a 12-year tertiary centre experience. Front Cardiovasc Med 2022;9:1066308. [PMID: 36561773 DOI: 10.3389/fcvm.2022.1066308][Reference Citation Analysis]
3
Szczepanska-Sadowska E. The Heart as a Target of Vasopressin and Other Cardiovascular Peptides in Health and Cardiovascular Diseases. Int J Mol Sci 2022;23. [PMID: 36430892 DOI: 10.3390/ijms232214414][Reference Citation Analysis]
4
Kotlyarov S. Genetic and Epigenetic Regulation of Lipoxygenase Pathways and Reverse Cholesterol Transport in Atherogenesis. Genes 2022;13:1474. [DOI: 10.3390/genes13081474][Reference Citation Analysis]